Professional Documents
Culture Documents
CLINDAMYCIN Drug Study
CLINDAMYCIN Drug Study
Drug Name: Inhibits protein synthesis INDICATION: CNS: Dizziness, Before Administration:
Clindamycin in susceptible bacteria at Treatment of: Skin and skin Headache, Vertigo Assessment: The nurse should assess the
the level of the 50S structure infections, Respiratory patient's medical history, including
ribosomes Tract Infections, Gynecolocogic CV: Arrythmias, allergies, previous adverse reactions to
Brand Name: Infections, Osteomyelitis, hypotension antibiotics, and current medications.
Cleocin Endocarditis prophylaxis.
CONTRAINDICATION: GI: Informed Consent: Ensure that the patient
Therapeutic Class: Hypersenxitivity; Previous Pseudomembranous understands the purpose, potential
Anti-Infectives oseudomembranous colitis, Severe colitis, Diarrhea, benefits, and risks associated with
liver impairment, Diarrhea Bitter taste(IV only), Clindamycin therapy, and obtain informed
DRUG TO DRUG INTERACTION: Nausea, Vomiting consent if required.
Dose:
May decreae GI absorption. May
300mg TID enhance the Neuromuscular Allergy Screening: Confirm whether the
blocking action of other patient has any known allergies,
Route: neuromuscular blocking agents. particularly to Clindamycin or other
IV antibiotics in the same class (such as
lincomycin).
During Administration:
Preparation: Prepare the medication
according to the prescriber's orders,
ensuring the correct dosage and route of
administration.
Verification: Verify the patient's identity
using two patient identifiers (e.g., name
and date of birth) and compare with the
medication administration record (MAR)
to prevent medication errors.
Administration: Administer Clindamycin
via the prescribed route (e.g., oral,
intravenous) following appropriate aseptic
techniques.
After Administration:
Observation: Continuously monitor the
patient for a reasonable period after
administration, particularly if the
medication is administered intravenously,
to detect any immediate adverse reactions.